Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD70 antibody

This Human Monoclonal antibody specifically detects CD70 in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7608421

Quick Overview for Recombinant CD70 antibody (ABIN7608421)

Target

See all CD70 Antibodies
CD70 (CD70 Molecule (CD70))

Antibody Type

Recombinant Antibody

Reactivity

  • 106
  • 16
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 68
  • 41
  • 5
  • 2
  • 1
  • 1
Human

Clonality

  • 67
  • 50
  • 1
Monoclonal

Conjugate

  • 64
  • 13
  • 9
  • 8
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD70 antibody is un-conjugated

Application

  • 53
  • 52
  • 50
  • 45
  • 23
  • 22
  • 20
  • 19
  • 11
  • 9
  • 8
  • 8
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
ELISA

Clone

5A4
  • Expression System

    HEK-293F Cells

    Purpose

    Cd70 Recombinant Antibody

    Characteristics

    The Cd70 Recombinant Antibody (Species: Human) has been validated for the following applications: ELISA.

    Purification

    Affinity-Chromatography

    Immunogen

    Recombinant Human Cd70 Protein

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Preservative: 0.03 % Proclin 300, Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

    Expiry Date

    12 months
  • Target

    CD70 (CD70 Molecule (CD70))

    Alternative Name

    CD70

    UniProt

    P32970

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!